Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q4 2020 (Next →)

Filing Date: Feb 16, 2021

Total Value: $584M (100.0% shares, 0.0% debt)

Holdings (30)

— SPDR SER TR 26.5%

Value $155M Shares 1,100,000 Est. Cost — Unrealized —

— MEDAVAIL HOLDINGS INC 7.5%

Value $43.96M Shares 2,920,780 Est. Cost $15.05 Unrealized —

AVIR ATEA PHARMACEUTICALS INC 7.3%

Value $42.48M Shares 1,016,688 Est. Cost $32.23 Unrealized 0.0%

— SAREPTA THERAPEUTICS INC 7.0%

Value $40.68M Shares 238,600 Est. Cost — Unrealized —

— CEREVEL THERAPEUTICS HLDNG I 5.0%

Value $29.3M Shares 1,767,440 Est. Cost $16.58 Unrealized —

— SYROS PHARMACEUTICALS INC 4.9%

Value $28.67M Shares 2,642,500 Est. Cost $10.85 Unrealized —

FATE FATE THERAPEUTICS INC 4.1%

Value $23.64M Shares 260,000 Est. Cost $62.10 Unrealized 0.0%

NTRA NATERA INC 3.2%

Value $18.71M Shares 188,000 Est. Cost $83.55 Unrealized 0.0%

COGT COGENT BIOSCIENCES INC 3.1%

Value $18.22M Shares 1,622,591 Est. Cost $10.99 Unrealized 0.0%

IOVA IOVANCE BIOTHERAPEUTICS INC 2.9%

Value $16.7M Shares 360,000 Est. Cost $39.70 Unrealized 0.0%

RGEN REPLIGEN CORP 2.7%

Value $15.81M Shares 82,500 Est. Cost $181.94 Unrealized 0.0%

CSTL CASTLE BIOSCIENCES INC 2.4%

Value $14.1M Shares 210,000 Est. Cost $54.21 Unrealized 0.0%

ORIC ORIC PHARMACEUTICALS INC 2.4%

Value $13.98M Shares 413,061 Est. Cost $28.69 Unrealized 0.0%

LUNG PULMONX CORP 2.4%

Value $13.74M Shares 199,122 Est. Cost $48.97 Unrealized 0.0%

APLS APELLIS PHARMACEUTICALS INC 2.3%

Value $13.16M Shares 230,000 Est. Cost $42.30 Unrealized 0.0%

NTLA INTELLIA THERAPEUTICS INC 2.1%

Value $12.24M Shares 225,000 Est. Cost $36.31 Unrealized 0.0%

AUPH AURINIA PHARMACEUTICALS INC 2.0%

Value $11.87M Shares 858,032 Est. Cost $14.55 Unrealized 0.0%

— ITEOS THERAPEUTICS INC 1.9%

Value $10.92M Shares 322,794 Est. Cost $33.82 Unrealized —

— ITAMAR MED LTD 1.7%

Value $9.969M Shares 501,964 Est. Cost $19.86 Unrealized —

ARVN ARVINAS INC 1.5%

Value $8.493M Shares 100,000 Est. Cost $34.48 Unrealized 0.0%

— FREELINE THERAPEUTICS HLDGS 1.3%

Value $7.761M Shares 425,000 Est. Cost $18.26 Unrealized —

VIR VIR BIOTECHNOLOGY INC 1.3%

Value $7.365M Shares 275,000 Est. Cost $32.50 Unrealized 0.0%

FDMT 4D MOLECULAR THERAPEUTICS IN 1.1%

Value $6.218M Shares 150,000 Est. Cost $41.28 Unrealized 0.0%

— APTOSE BIOSCIENCES INC 1.1%

Value $6.172M Shares 1,409,150 Est. Cost $4.38 Unrealized —

SPRY SILVERBACK THERAPEUTICS INC 1.0%

Value $5.958M Shares 128,572 Est. Cost $33.40 Unrealized 0.0%

— CHINOOK THERAPEUTICS INC 0.5%

Value $3.166M Shares 199,600 Est. Cost $15.86 Unrealized —

— ORCHARD THERAPEUTICS PLC 0.4%

Value $2.365M Shares 547,427 Est. Cost $4.32 Unrealized —

— ONCTERNAL THERAPEUTICS INC 0.3%

Value $1.47M Shares 300,000 Est. Cost $4.90 Unrealized —

— ESSA PHARMA INC 0.2%

Value $933K Shares 78,185 Est. Cost $11.93 Unrealized —

— NANOSTRING TECHNOLOGIES INC 0.1%

Value $620K Shares 9,277 Est. Cost $66.83 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	SPDR SER TR	1,100,000	$155M	26.5%	—	—	Put	78464A950
—	MEDAVAIL HOLDINGS INC	2,920,780	$43.96M	7.5%	$15.05	—	COM	58406B103
AVIR	ATEA PHARMACEUTICALS INC	1,016,688	$42.48M	7.3%	$32.23	0.0%	COM	04683R106
—	SAREPTA THERAPEUTICS INC	238,600	$40.68M	7.0%	—	—	Call	803607900
—	CEREVEL THERAPEUTICS HLDNG I	1,767,440	$29.3M	5.0%	$16.58	—	COM	15678U128
—	SYROS PHARMACEUTICALS INC	2,642,500	$28.67M	4.9%	$10.85	—	COM	87184Q107
FATE	FATE THERAPEUTICS INC	260,000	$23.64M	4.1%	$62.10	0.0%	COM	31189P102
NTRA	NATERA INC	188,000	$18.71M	3.2%	$83.55	0.0%	COM	632307104
COGT	COGENT BIOSCIENCES INC	1,622,591	$18.22M	3.1%	$10.99	0.0%	COM	19240Q201
IOVA	IOVANCE BIOTHERAPEUTICS INC	360,000	$16.7M	2.9%	$39.70	0.0%	COM	462260100
RGEN	REPLIGEN CORP	82,500	$15.81M	2.7%	$181.94	0.0%	COM	759916109
CSTL	CASTLE BIOSCIENCES INC	210,000	$14.1M	2.4%	$54.21	0.0%	COM	14843C105
ORIC	ORIC PHARMACEUTICALS INC	413,061	$13.98M	2.4%	$28.69	0.0%	COM	68622P109
LUNG	PULMONX CORP	199,122	$13.74M	2.4%	$48.97	0.0%	COM	745848101
APLS	APELLIS PHARMACEUTICALS INC	230,000	$13.16M	2.3%	$42.30	0.0%	COM	03753U106
NTLA	INTELLIA THERAPEUTICS INC	225,000	$12.24M	2.1%	$36.31	0.0%	COM	45826J105
AUPH	AURINIA PHARMACEUTICALS INC	858,032	$11.87M	2.0%	$14.55	0.0%	COM	05156V102
—	ITEOS THERAPEUTICS INC	322,794	$10.92M	1.9%	$33.82	—	COM	46565G104
—	ITAMAR MED LTD	501,964	$9.969M	1.7%	$19.86	—	SPONSORED ADS	465437101
ARVN	ARVINAS INC	100,000	$8.493M	1.5%	$34.48	0.0%	COM	04335A105
—	FREELINE THERAPEUTICS HLDGS	425,000	$7.761M	1.3%	$18.26	—	SPONSORED ADS	35655L107
VIR	VIR BIOTECHNOLOGY INC	275,000	$7.365M	1.3%	$32.50	0.0%	COM	92764N102
FDMT	4D MOLECULAR THERAPEUTICS IN	150,000	$6.218M	1.1%	$41.28	0.0%	COM	35104E100
—	APTOSE BIOSCIENCES INC	1,409,150	$6.172M	1.1%	$4.38	—	COM NEW	03835T200
SPRY	SILVERBACK THERAPEUTICS INC	128,572	$5.958M	1.0%	$33.40	0.0%	COM	82835W108
—	CHINOOK THERAPEUTICS INC	199,600	$3.166M	0.5%	$15.86	—	COM	16961L106
—	ORCHARD THERAPEUTICS PLC	547,427	$2.365M	0.4%	$4.32	—	ADS	68570P101
—	ONCTERNAL THERAPEUTICS INC	300,000	$1.47M	0.3%	$4.90	—	COM	68236P107
—	ESSA PHARMA INC	78,185	$933K	0.2%	$11.93	—	COM NEW	29668H708
—	NANOSTRING TECHNOLOGIES INC	9,277	$620K	0.1%	$66.83	—	COM	63009R109